1-4 of 4
Alexander Fefer
Close
Sort by
Journal Articles

Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)

Clinical Trials & Observations
John A. Thompson, Richard I. Fisher, Michael LeBlanc, Stephen J. Forman, Oliver W. Press, Joseph M. Unger, Auayporn P. Nademanee, Patrick J. Stiff, Stephen H. Petersdorf, Alexander Fefer
Journal: Blood
Blood (2008) 111 (8): 4048–4054.
https://doi.org/10.1182/blood-2007-09-111708
Published: 2008
Journal Articles

Total Body Irradiation, Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation Followed by Randomization to Therapy with Interleukin-2 Versus Observation for Patients with Non-Hodgkin’s Lymphoma: Results of a Phase III Randomized Trial by the Southwest Oncology Group (SWOG 9438).

John A. Thompson, MD, Richard I. Fisher, MD, Michael L. LeBlanc, PhD, Joseph M. Unger, MS, Stephen J. Forman, MD, Patrick J. Stiff, MD, Alexander Fefer, MD
Journal: Blood
Blood (2006) 108 (11): 326.
https://doi.org/10.1182/blood.V108.11.326.326
Published: 2006
Journal Articles

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation

Clinical Trials & Observations
Kristina M. Adams, Leona A. Holmberg, Wendy Leisenring, Alexander Fefer, Katherine A. Guthrie, Tracy S. Tylee, George B. McDonald, William I. Bensinger, J. Lee Nelson
Journal: Blood
Blood (2004) 104 (6): 1894–1897.
https://doi.org/10.1182/blood-2004-02-0508
Published: 2004
Journal Articles

“Special delivery” to cancer cells

Alexander Fefer
Journal: Blood
Blood (2002) 99 (5): 1503–1504.
https://doi.org/10.1182/blood.V99.5.1503a
Published: 2002